These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3890316

  • 1. Monitoring progression of diabetic nephropathy.
    Parving HH, Andersen AR, Smidt UM.
    Ups J Med Sci; 1985; 90(1):15-23. PubMed ID: 3890316
    [Abstract] [Full Text] [Related]

  • 2. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC, Bilous RW, Mackintosh D, Keen H.
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [Abstract] [Full Text] [Related]

  • 3. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA, Ozmen D, Ozmen B, Parildar Z, Mutaf I, Turgan N, Habif S, Kumanlioğluc K, Bayindir O.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [Abstract] [Full Text] [Related]

  • 4. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [Abstract] [Full Text] [Related]

  • 5. Estimation of renal function in diabetic nephropathy. Comparison of five methods.
    Nordén G, Björck S, Granerus G, Nyberg G.
    Nephron; 1987 Aug; 47(1):36-42. PubMed ID: 3114657
    [Abstract] [Full Text] [Related]

  • 6. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
    Jialal I, Nathoo BC, Bejai S, Joubert SM.
    S Afr Med J; 1982 Jun 19; 61(25):953-4. PubMed ID: 6178173
    [Abstract] [Full Text] [Related]

  • 7. Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics.
    Viberti GC, Keen H, Mackintosh D.
    Br Med J (Clin Res Ed); 1981 Jan 10; 282(6258):95-8. PubMed ID: 6161671
    [Abstract] [Full Text] [Related]

  • 8. Predictors of renal function in diabetic and non-diabetic renal disease.
    Feehally J, Taverner D, Burden AC, Walls J.
    Clin Chim Acta; 1983 Sep 30; 133(2):169-75. PubMed ID: 6354517
    [Abstract] [Full Text] [Related]

  • 9. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine.
    Sampson MJ, Drury PL.
    Diabetes Care; 1992 May 30; 15(5):609-12. PubMed ID: 1516478
    [Abstract] [Full Text] [Related]

  • 10. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M.
    Kidney Int; 2002 Apr 30; 61(4):1453-61. PubMed ID: 11918752
    [Abstract] [Full Text] [Related]

  • 11. Measurement of glomerular filtration rate in homozygous sickle cell disease: a comparison of 51Cr-EDTA clearance, creatinine clearance, serum creatinine and beta 2 microglobulin.
    Aparicio SA, Mojiminiyi S, Kay JD, Shepstone BJ, de Ceulaer K, Serjeant GR.
    J Clin Pathol; 1990 May 30; 43(5):370-2. PubMed ID: 2115049
    [Abstract] [Full Text] [Related]

  • 12. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.
    Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR.
    Diabetologia; 1981 Apr 30; 20(4):457-61. PubMed ID: 7016639
    [Abstract] [Full Text] [Related]

  • 13. [Early detection of diabetic nephropathy: serum beta 2-microglobulin].
    Goebel FD, Schmeidl T, Füessl HS, Vogel S.
    Klin Wochenschr; 1983 Dec 01; 61(23):1209-15. PubMed ID: 6361371
    [Abstract] [Full Text] [Related]

  • 14. [Is the serum level of beta 2 microglobulin a better marker of glomerular filtration than blood creatinine?].
    François B, Assenat H, Cahen R, Bizollon C.
    Nephrologie; 1982 Dec 01; 3(3):116-8. PubMed ID: 6183598
    [Abstract] [Full Text] [Related]

  • 15. Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin.
    Trollfors B, Norrby R.
    Nephron; 1981 Dec 01; 28(4):196-9. PubMed ID: 6170902
    [Abstract] [Full Text] [Related]

  • 16. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
    Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH.
    Diabetes Care; 2006 May 01; 29(5):1024-30. PubMed ID: 16644632
    [Abstract] [Full Text] [Related]

  • 17. Human alpha 1-microglobulin and its relationship to renal function.
    Kusano E, Suzuki M, Asano Y, Itoh Y, Takagi K, Kawai T.
    Nephron; 1985 May 01; 41(4):320-4. PubMed ID: 2415841
    [Abstract] [Full Text] [Related]

  • 18. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.
    J Intern Med; 2004 Dec 01; 256(6):510-8. PubMed ID: 15554952
    [Abstract] [Full Text] [Related]

  • 19. Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy.
    Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD.
    Am J Kidney Dis; 1990 Sep 01; 16(3):236-43. PubMed ID: 2399915
    [Abstract] [Full Text] [Related]

  • 20. Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of 51Cr-EDTA.
    Hansen HP, Rossing P, Mathiesen ER, Hommel E, Smidt UM, Parving HH.
    Scand J Clin Lab Invest; 1998 Aug 01; 58(5):405-13. PubMed ID: 9819189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.